DCF — AMERICAN ONCOLOGIC HOSPIAL
Enterprise Value: $-400.3M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-400.3M
Enterprise Value
$-126.2M
PV of Cash Flows
$-274.1M
PV of Terminal Value
$-441.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $236.7M | $-25.2M | -11.0% | $-35.2M | $-32.0M |
| Year 2 | $243.8M | $-23.5M | -10.0% | $-33.8M | $-28.0M |
| Year 3 | $251.2M | $-21.7M | -9.0% | $-32.3M | $-24.3M |
| Year 4 | $258.7M | $-21.1M | -8.0% | $-32.0M | $-21.9M |
| Year 5 | $266.5M | $-21.0M | -8.0% | $-32.3M | $-20.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-400.3M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$229.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11140282013687366
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5